APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Liquid Biopsy Products

Liquid biopsies are a sequencing-based technology used to screen blood for tiny fragments of genetic material released by cancer tissue, known as circulating tumor (ct) DNA.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Liquid biopsies are a sequencing-based technology used to screen blood for tiny fragments of genetic material released by cancer tissue, known as circulating tumor (ct) DNA.

This report mainly covers the Liquid Biopsy Products product type by technology (circulating Tumor Cells (CTCs), circulating tumor DNA (ctDNA), and extracellular vesicles (or exosomes)), by sample type (blood, urine and other bio fluids (Tissue fluids and Saliva based)), while we can also offer any product survey report related to the liquid biopsy products industry chain.

Selected research

Market Outlook & Growth Opportunities

Global Liquid Biopsy Products Market Outlook and Growth Opportunities 2026

1 January 2026199 pages

Choose your research edition.

Industry ResearchLiquid Biopsy Products Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Liquid Biopsy Products Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Liquid Biopsy Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Liquid Biopsy Products Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Liquid Biopsy Products Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Liquid biopsies are a sequencing-based technology used to screen blood for tiny fragments of genetic material released by cancer tissue, known as circulating tumor (ct) DNA.

This report mainly covers the Liquid Biopsy Products product type by technology (circulating Tumor Cells (CTCs), circulating tumor DNA (ctDNA), and extracellular vesicles (or exosomes)), by sample type (blood, urine and other bio fluids (Tissue fluids and Saliva based)), while we can also offer any product survey report related to the liquid biopsy products industry chain.

The major players in global Liquid Biopsy Products market include RainDanceTechnologies, Biocartis, Qiagen, etc. The top 3 players occupy about 15% shares of the global market. North America is the main market. CTCs is the main type, with a share about 65%. Blood Sample is the main application, which holds a share about 90%.

Read the full market overview

This report provides an overview of the global Liquid Biopsy Products market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Liquid Biopsy Products and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Liquid Biopsy Products revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Liquid Biopsy Products market.

Liquid Biopsy Products Segment by Company

RainDanceTechnologies

Biocartis

Qiagen

Guardant Health

MDxHealth

Pathway Genomics

NeoGenomics Laboraories

Sysmex Inostics

Cynvenio

Menarini Silicon Biosystems

Adaptive Biotechnologies

Biocept

Angle plc

Liquid Biopsy Products Segment by Type

CTCs

ctDNA

Exosomes

Liquid Biopsy Products Segment by Application

Blood Sample

Urine Sample

Other Bio Fluids

Liquid Biopsy Products Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Liquid Biopsy Products status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Liquid Biopsy Products key companies, revenue, market share, and recent developments.

3. To split the Liquid Biopsy Products breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Liquid Biopsy Products market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Liquid Biopsy Products significant trends, drivers, influence factors in global and regions.

6. To analyze Liquid Biopsy Products competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liquid Biopsy Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Liquid Biopsy Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liquid Biopsy Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Liquid Biopsy Products industry.

Chapter 3: Detailed analysis of Liquid Biopsy Products company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Liquid Biopsy Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Liquid Biopsy Products in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Liquid Biopsy Products Industry Trends Table 2. Liquid Biopsy Products Industry Drivers Table 3. Liquid Biopsy Products Industry Opportunities and Challenges Table 4. Liquid Biopsy Products Industry Restraints Table 5. Global Liquid Biopsy Products Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Liquid Biopsy Products Revenue Share by Company (2021-2026) Table 7. Global Liquid Biopsy Products Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Liquid Biopsy Products Key Company Manufacturing Base & Headquarters Table 9. Global Liquid Biopsy Products Company, Product Type & Application Table 10. Global Liquid Biopsy Products Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Liquid Biopsy Products by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of CTCs Table 15. Significant Companies of ctDNA Table 16. Significant Companies of Exosomes Table 17. Global Liquid Biopsy Products Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Liquid Biopsy Products Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Liquid Biopsy Products Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Liquid Biopsy Products Sales Value Share by Type (2021-2026) Table 21. Global Liquid Biopsy Products Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Blood Sample Table 23. Significant Companies of Urine Sample Table 24. Significant Companies of Other Bio Fluids Table 25. Global Liquid Biopsy Products Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Liquid Biopsy Products Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Liquid Biopsy Products Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Liquid Biopsy Products Sales Value Share by Application (2021-2026) Table 29. Global Liquid Biopsy Products Sales Value Share by Application (2027-2032) Table 30. Global Liquid Biopsy Products Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Liquid Biopsy Products Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Liquid Biopsy Products Sales Value Share by Region (2021-2026) Table 33. Global Liquid Biopsy Products Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Liquid Biopsy Products Sales Value Share by Region (2027-2032) Table 35. Global Liquid Biopsy Products Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Liquid Biopsy Products Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Liquid Biopsy Products Sales Value Market Share by Country (2021-2026) Table 38. Global Liquid Biopsy Products Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Liquid Biopsy Products Sales Value Market Share by Country (2027-2032) Table 40. RainDanceTechnologies Company Information Table 41. RainDanceTechnologies Business Overview Table 42. RainDanceTechnologies Liquid Biopsy Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. RainDanceTechnologies Liquid Biopsy Products Product Portfolio Table 44. RainDanceTechnologies Recent Development Table 45. Biocartis Company Information Table 46. Biocartis Business Overview Table 47. Biocartis Liquid Biopsy Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Biocartis Liquid Biopsy Products Product Portfolio Table 49. Biocartis Recent Development Table 50. Qiagen Company Information Table 51. Qiagen Business Overview Table 52. Qiagen Liquid Biopsy Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Qiagen Liquid Biopsy Products Product Portfolio Table 54. Qiagen Recent Development Table 55. Guardant Health Company Information Table 56. Guardant Health Business Overview Table 57. Guardant Health Liquid Biopsy Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Guardant Health Liquid Biopsy Products Product Portfolio Table 59. Guardant Health Recent Development Table 60. MDxHealth Company Information Table 61. MDxHealth Business Overview Table 62. MDxHealth Liquid Biopsy Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. MDxHealth Liquid Biopsy Products Product Portfolio Table 64. MDxHealth Recent Development Table 65. Pathway Genomics Company Information Table 66. Pathway Genomics Business Overview Table 67. Pathway Genomics Liquid Biopsy Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Pathway Genomics Liquid Biopsy Products Product Portfolio Table 69. Pathway Genomics Recent Development Table 70. NeoGenomics Laboraories Company Information Table 71. NeoGenomics Laboraories Business Overview Table 72. NeoGenomics Laboraories Liquid Biopsy Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. NeoGenomics Laboraories Liquid Biopsy Products Product Portfolio Table 74. NeoGenomics Laboraories Recent Development Table 75. Sysmex Inostics Company Information Table 76. Sysmex Inostics Business Overview Table 77. Sysmex Inostics Liquid Biopsy Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Sysmex Inostics Liquid Biopsy Products Product Portfolio Table 79. Sysmex Inostics Recent Development Table 80. Cynvenio Company Information Table 81. Cynvenio Business Overview Table 82. Cynvenio Liquid Biopsy Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Cynvenio Liquid Biopsy Products Product Portfolio Table 84. Cynvenio Recent Development Table 85. Menarini Silicon Biosystems Company Information Table 86. Menarini Silicon Biosystems Business Overview Table 87. Menarini Silicon Biosystems Liquid Biopsy Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Menarini Silicon Biosystems Liquid Biopsy Products Product Portfolio Table 89. Menarini Silicon Biosystems Recent Development Table 90. Adaptive Biotechnologies Company Information Table 91. Adaptive Biotechnologies Business Overview Table 92. Adaptive Biotechnologies Liquid Biopsy Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Adaptive Biotechnologies Liquid Biopsy Products Product Portfolio Table 94. Adaptive Biotechnologies Recent Development Table 95. Biocept Company Information Table 96. Biocept Business Overview Table 97. Biocept Liquid Biopsy Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Biocept Liquid Biopsy Products Product Portfolio Table 99. Biocept Recent Development Table 100. Angle plc Company Information Table 101. Angle plc Business Overview Table 102. Angle plc Liquid Biopsy Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Angle plc Liquid Biopsy Products Product Portfolio Table 104. Angle plc Recent Development Table 105. Research Programs/Design for This Report Table 106. Authors List of This Report Table 107. Secondary Sources Table 108. Primary Sources List of Figures Figure 1. Liquid Biopsy Products Product Image Figure 2. Global Liquid Biopsy Products Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Liquid Biopsy Products Market Size (2021-2032) & (US$ Million) Figure 4. Global Liquid Biopsy Products Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. CTCs Image Figure 8. ctDNA Image Figure 9. Exosomes Image Figure 10. Global Liquid Biopsy Products Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Liquid Biopsy Products Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Liquid Biopsy Products Sales Value Share by Type (2021-2032) Figure 13. Blood Sample Image Figure 14. Urine Sample Image Figure 15. Other Bio Fluids Image Figure 16. Global Liquid Biopsy Products Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Liquid Biopsy Products Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Liquid Biopsy Products Sales Value Share by Application (2021-2032) Figure 19. Global Liquid Biopsy Products Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Liquid Biopsy Products Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Liquid Biopsy Products Sales Value (2021-2032) & (US$ Million) Figure 22. North America Liquid Biopsy Products Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Liquid Biopsy Products Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Liquid Biopsy Products Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Liquid Biopsy Products Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Liquid Biopsy Products Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Liquid Biopsy Products Sales Value (2021-2032) & (US$ Million) Figure 28. South America Liquid Biopsy Products Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Liquid Biopsy Products Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Liquid Biopsy Products Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Liquid Biopsy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Liquid Biopsy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Liquid Biopsy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Liquid Biopsy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Liquid Biopsy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Liquid Biopsy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Liquid Biopsy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Liquid Biopsy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Liquid Biopsy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Liquid Biopsy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Liquid Biopsy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Liquid Biopsy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Liquid Biopsy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Liquid Biopsy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Liquid Biopsy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Liquid Biopsy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Liquid Biopsy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Liquid Biopsy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Liquid Biopsy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Liquid Biopsy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Liquid Biopsy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Liquid Biopsy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Liquid Biopsy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Liquid Biopsy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Liquid Biopsy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Liquid Biopsy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Liquid Biopsy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Liquid Biopsy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • CTCs
  • ctDNA
  • Exosomes
Applications
  • Blood Sample
  • Urine Sample
  • Other Bio Fluids
Companies covered
  • RainDanceTechnologies
  • Biocartis
  • Qiagen
  • Guardant Health
  • MDxHealth
  • Pathway Genomics
  • NeoGenomics Laboraories
  • Sysmex Inostics
  • Cynvenio
  • Menarini Silicon Biosystems
  • Adaptive Biotechnologies
  • Biocept
  • Angle plc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Liquid Biopsy Products Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Liquid Biopsy Products Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Liquid Biopsy Products Market Dynamics
  1. 2.1 Liquid Biopsy Products Industry Trends
  2. 2.2 Liquid Biopsy Products Industry Drivers
  3. 2.3 Liquid Biopsy Products Industry Opportunities and Challenges
  4. 2.4 Liquid Biopsy Products Industry Restraints
3 Liquid Biopsy Products Market by Company
  1. 3.1 Global Liquid Biopsy Products Company Revenue Ranking in 2025
  2. 3.2 Global Liquid Biopsy Products Revenue by Company (2021-2026)
  3. 3.3 Global Liquid Biopsy Products Company Ranking (2024-2026)
  4. 3.4 Global Liquid Biopsy Products Company Manufacturing Base and Headquarters
  5. 3.5 Global Liquid Biopsy Products Company Product Type and Application
  6. 3.6 Global Liquid Biopsy Products Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Liquid Biopsy Products Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Liquid Biopsy Products Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Liquid Biopsy Products Market by Type
  1. 4.1 Liquid Biopsy Products Type Introduction
  2. 4.1.1 CTCs
  3. 4.1.2 ctDNA
  4. 4.1.3 Exosomes
  5. 4.2 Global Liquid Biopsy Products Sales Value by Type
  6. 4.2.1 Global Liquid Biopsy Products Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Liquid Biopsy Products Sales Value by Type (2021-2032)
  8. 4.2.3 Global Liquid Biopsy Products Sales Value Share by Type (2021-2032)
5 Liquid Biopsy Products Market by Application
  1. 5.1 Liquid Biopsy Products Application Introduction
  2. 5.1.1 Blood Sample
  3. 5.1.2 Urine Sample
  4. 5.1.3 Other Bio Fluids
  5. 5.2 Global Liquid Biopsy Products Sales Value by Application
  6. 5.2.1 Global Liquid Biopsy Products Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Liquid Biopsy Products Sales Value by Application (2021-2032)
  8. 5.2.3 Global Liquid Biopsy Products Sales Value Share by Application (2021-2032)
6 Liquid Biopsy Products Regional Value Analysis
  1. 6.1 Global Liquid Biopsy Products Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Liquid Biopsy Products Sales Value by Region (2021-2032)
  3. 6.2.1 Global Liquid Biopsy Products Sales Value by Region: 2021-2026
  4. 6.2.2 Global Liquid Biopsy Products Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Liquid Biopsy Products Sales Value (2021-2032)
  7. 6.3.2 North America Liquid Biopsy Products Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Liquid Biopsy Products Sales Value (2021-2032)
  10. 6.4.2 Europe Liquid Biopsy Products Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Liquid Biopsy Products Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Liquid Biopsy Products Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Liquid Biopsy Products Sales Value (2021-2032)
  16. 6.6.2 South America Liquid Biopsy Products Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Liquid Biopsy Products Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Liquid Biopsy Products Sales Value Share by Country, 2025 VS 2032
7 Liquid Biopsy Products Country-level Value Analysis
  1. 7.1 Global Liquid Biopsy Products Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Liquid Biopsy Products Sales Value by Country (2021-2032)
  3. 7.2.1 Global Liquid Biopsy Products Sales Value by Country (2021-2026)
  4. 7.2.2 Global Liquid Biopsy Products Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Liquid Biopsy Products Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Liquid Biopsy Products Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Liquid Biopsy Products Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Liquid Biopsy Products Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Liquid Biopsy Products Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Liquid Biopsy Products Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Liquid Biopsy Products Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Liquid Biopsy Products Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Liquid Biopsy Products Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Liquid Biopsy Products Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Liquid Biopsy Products Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Liquid Biopsy Products Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Liquid Biopsy Products Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Liquid Biopsy Products Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Liquid Biopsy Products Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Liquid Biopsy Products Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Liquid Biopsy Products Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Liquid Biopsy Products Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Liquid Biopsy Products Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Liquid Biopsy Products Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Liquid Biopsy Products Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Liquid Biopsy Products Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Liquid Biopsy Products Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Liquid Biopsy Products Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Liquid Biopsy Products Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Liquid Biopsy Products Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Liquid Biopsy Products Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Liquid Biopsy Products Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Liquid Biopsy Products Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Liquid Biopsy Products Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 RainDanceTechnologies
  2. 8.1.1 RainDanceTechnologies Company Information
  3. 8.1.2 RainDanceTechnologies Business Overview
  4. 8.1.3 RainDanceTechnologies Liquid Biopsy Products Revenue and Gross Margin (2021-2026)
  5. 8.1.4 RainDanceTechnologies Liquid Biopsy Products Product Portfolio
  6. 8.1.5 RainDanceTechnologies Recent Developments
  7. 8.2 Biocartis
  8. 8.2.1 Biocartis Company Information
  9. 8.2.2 Biocartis Business Overview
  10. 8.2.3 Biocartis Liquid Biopsy Products Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Biocartis Liquid Biopsy Products Product Portfolio
  12. 8.2.5 Biocartis Recent Developments
  13. 8.3 Qiagen
  14. 8.3.1 Qiagen Company Information
  15. 8.3.2 Qiagen Business Overview
  16. 8.3.3 Qiagen Liquid Biopsy Products Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Qiagen Liquid Biopsy Products Product Portfolio
  18. 8.3.5 Qiagen Recent Developments
  19. 8.4 Guardant Health
  20. 8.4.1 Guardant Health Company Information
  21. 8.4.2 Guardant Health Business Overview
  22. 8.4.3 Guardant Health Liquid Biopsy Products Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Guardant Health Liquid Biopsy Products Product Portfolio
  24. 8.4.5 Guardant Health Recent Developments
  25. 8.5 MDxHealth
  26. 8.5.1 MDxHealth Company Information
  27. 8.5.2 MDxHealth Business Overview
  28. 8.5.3 MDxHealth Liquid Biopsy Products Revenue and Gross Margin (2021-2026)
  29. 8.5.4 MDxHealth Liquid Biopsy Products Product Portfolio
  30. 8.5.5 MDxHealth Recent Developments
  31. 8.6 Pathway Genomics
  32. 8.6.1 Pathway Genomics Company Information
  33. 8.6.2 Pathway Genomics Business Overview
  34. 8.6.3 Pathway Genomics Liquid Biopsy Products Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pathway Genomics Liquid Biopsy Products Product Portfolio
  36. 8.6.5 Pathway Genomics Recent Developments
  37. 8.7 NeoGenomics Laboraories
  38. 8.7.1 NeoGenomics Laboraories Company Information
  39. 8.7.2 NeoGenomics Laboraories Business Overview
  40. 8.7.3 NeoGenomics Laboraories Liquid Biopsy Products Revenue and Gross Margin (2021-2026)
  41. 8.7.4 NeoGenomics Laboraories Liquid Biopsy Products Product Portfolio
  42. 8.7.5 NeoGenomics Laboraories Recent Developments
  43. 8.8 Sysmex Inostics
  44. 8.8.1 Sysmex Inostics Company Information
  45. 8.8.2 Sysmex Inostics Business Overview
  46. 8.8.3 Sysmex Inostics Liquid Biopsy Products Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sysmex Inostics Liquid Biopsy Products Product Portfolio
  48. 8.8.5 Sysmex Inostics Recent Developments
  49. 8.9 Cynvenio
  50. 8.9.1 Cynvenio Company Information
  51. 8.9.2 Cynvenio Business Overview
  52. 8.9.3 Cynvenio Liquid Biopsy Products Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Cynvenio Liquid Biopsy Products Product Portfolio
  54. 8.9.5 Cynvenio Recent Developments
  55. 8.10 Menarini Silicon Biosystems
  56. 8.10.1 Menarini Silicon Biosystems Company Information
  57. 8.10.2 Menarini Silicon Biosystems Business Overview
  58. 8.10.3 Menarini Silicon Biosystems Liquid Biopsy Products Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Menarini Silicon Biosystems Liquid Biopsy Products Product Portfolio
  60. 8.10.5 Menarini Silicon Biosystems Recent Developments
  61. 8.11 Adaptive Biotechnologies
  62. 8.11.1 Adaptive Biotechnologies Company Information
  63. 8.11.2 Adaptive Biotechnologies Business Overview
  64. 8.11.3 Adaptive Biotechnologies Liquid Biopsy Products Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Adaptive Biotechnologies Liquid Biopsy Products Product Portfolio
  66. 8.11.5 Adaptive Biotechnologies Recent Developments
  67. 8.12 Biocept
  68. 8.12.1 Biocept Company Information
  69. 8.12.2 Biocept Business Overview
  70. 8.12.3 Biocept Liquid Biopsy Products Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Biocept Liquid Biopsy Products Product Portfolio
  72. 8.12.5 Biocept Recent Developments
  73. 8.13 Angle plc
  74. 8.13.1 Angle plc Company Information
  75. 8.13.2 Angle plc Business Overview
  76. 8.13.3 Angle plc Liquid Biopsy Products Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Angle plc Liquid Biopsy Products Product Portfolio
  78. 8.13.5 Angle plc Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst